BALAMINES
530999Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Analyst/Investor Meet
Balaji Amines maintains a significant presence across major geographies, exporting products to more than 40 countries and maintaining long-term relationships with global clients. The company leverages integrated production capabilities and backward integration to drive quality, cost-effectiveness, and timely delivery, positioning itself as a preferred partner for bulk and specialty chemicals.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Analyst/Investor Meet
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Analysts/ Investors meet under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Balaji Amines Ltd
About
Balaji Amines maintains a significant presence across major geographies, exporting products to more than 40 countries and maintaining long-term relationships with global clients. The company leverages integrated production capabilities and backward integration to drive quality, cost-effectiveness, and timely delivery, positioning itself as a preferred partner for bulk and specialty chemicals.
Business Model & Strategy
Balaji Amines Ltd generates revenue through the production and sale of aliphatic amines (including methylamines, ethylamines, and derivatives), specialty chemicals, and performance-based products. Its business model emphasizes cost leadership, operational integration, and strategic expansion into higher-value derivatives and niche chemical segments. The company is engaging in capacity expansion, technology upgrades, and product diversification – notably through new plant setups and greenfield projects to strengthen its specialty chemicals portfolio.
Growth vectors include broadening export markets, developing downstream derivatives for pharmaceutical and agrochemical use, and enhancing operational efficiencies via energy management and digitalization. Strategic focus areas also include ESG compliance, sustainable manufacturing practices, and deeper R&D investments to enter new end-use industries.
Management Overview
9 MembersMr.ANDE PRATHAP REDDY
Executive Director-Chairperson related to PromoterMr.RAJESHWAR REDDY NOMULA
Executive DirectorMr.DUNDURAPU RAM REDDY
Executive Director-MDMr.ANDE SRINIVAS REDDY
Executive DirectorMrs.SUHASINI YATIN SHAH
Non-Executive - Independent DirectorMrs.UMA RAJIV PRADHAN
Non-Executive - Independent DirectorMr.MOHAN KUMAR RAMAKRISHNA
Non-Executive - Independent DirectorMr.ADABALA SESHAGIRI RAO
Non-Executive - Independent DirectorMr.Abhijeet S. Kothadiya
Company Secretary & Compliance OfficerAwards & Recognition
5 Awards- CNBC-TV18 India Business Leader Awards 2024 – Shortlisted in Large Corporates category
- ISO 9001:2015, ISO 14001:2015 & ISO 45001:2018 certified facilities
- Recognized as one of India's Top 500 Companies by Dun & Bradstreet (2023, 2024)
- Consistent 'Excellent' supplier ratings from leading global pharmaceutical clients
- Received 'Zero Liquid Discharge' certification for environmental compliance at manufacturing sites
Market Information
Company Timeline
36+ Years of Excellence | 9 Major Milestones
Incorporated as Balaji Amines Ltd in Solapur, Maharashtra
Commissioned first methylamines plant
Listed on the Bombay Stock Exchange (BSE)
Listed on National Stock Exchange (NSE)
Commenced commercial production of dimethylformamide (DMF)
Expansion into additional derivatives and specialty chemicals
Established new greenfield plant for specialty chemicals at Solapur MIDC
Launched forward integration project for acetonitrile and N-Methyl-2-Pyrrolidone (NMP) line
Commissioned new energy-efficient manufacturing facility and ramped up R&D investments
The Next Evolution
Contact Information
Registered Office
Gat no. 9/1/A/1, Balaji Towers, Hotgi Road, Aasara Chowk
Tel: 0217-2451523 / 24 / 310822 / 23 / 24 / 25 / 28,
Fax: 0217-(040 - 27816171),
Email: cs@balajiamines.com; info@balajiamines.com
Website: balajiamines.com
Registrars
Venture Capital & Corporate Investments Pvt. Ltd
Tel: 040 - 23818475/23868257/35164940
Corporate Actions
13| Purpose | Ex Date | Record Date | BC Start | BC End |
|---|---|---|---|---|
Final Dividend ₹11 per share | 03 Jul 2026 Friday | 03 Jul 2026 Friday | - | - |
Final Dividend ₹11 per share | 01 Aug 2025 Friday | 01 Aug 2025 Friday | - | - |
Final Dividend ₹11 per share | 04 Jul 2024 Thursday | - | 05 Jul 2024 Friday | 11 Jul 2024 Thursday |
Final Dividend ₹10 per share | 03 Jul 2023 Monday | - | 04 Jul 2023 Tuesday | 10 Jul 2023 Monday |
Final Dividend ₹6 per share | 21 Jun 2022 Tuesday | - | 23 Jun 2022 Thursday | 29 Jun 2022 Wednesday |
Final Dividend ₹4 per share | 29 Jul 2021 Thursday | - | 02 Aug 2021 Monday | 09 Aug 2021 Monday |
Final Dividend ₹0.60 per share | 30 Jul 2020 Thursday | - | 01 Aug 2020 Saturday | 08 Aug 2020 Saturday |
Interim Dividend ₹2.60 per share | 17 Mar 2020 Tuesday | 18 Mar 2020 Wednesday | - | - |
Dividend ₹2.80 per share | 17 Jul 2019 Wednesday | - | 19 Jul 2019 Friday | 26 Jul 2019 Friday |
Dividend ₹2.60 per share | 20 Aug 2018 Monday | - | 23 Aug 2018 Thursday | 30 Aug 2018 Thursday |
Dividend ₹2.20 per share | 20 Jul 2017 Thursday | - | 22 Jul 2017 Saturday | 31 Jul 2017 Monday |
Dividend ₹2 per share | 21 Jul 2016 Thursday | - | 24 Jul 2016 Sunday | 30 Jul 2016 Saturday |
Dividend ₹1.20 per share | 15 Sep 2015 Tuesday | - | 17 Sep 2015 Thursday | 23 Sep 2015 Wednesday |
₹7,776 Cr.
₹2,408
₹2,461 / 968
33.06
₹664.09
3.61
₹72.6
₹2.00
0.46 %
Manage Ratio
FINANCIALS
| Annual Results | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income | - | - | - | 947 | 941 | 1,318 | 2,328 | 2,371 | 1,671 | 1,430 | 1,454 | 1,915 |
| Expenses | - | - | - | 782 | 810 | 991 | 1,749 | 1,804 | 1,370 | 1,217 | 1,221 | 1,577 |
| Profit | - | - | - | 117 | 97 | 243 | 418 | 406 | 232 | 159 | 169 | 247 |
| Tax | - | - | - | 52 | 38 | 83 | 160 | 161 | 69 | 55 | 63 | 91 |
| EPS | - | - | - | 36 | 32 | 74 | 114 | 100 | 63 | 49 | 52 | 23.13 |
| Ratios | - |
Cash Flow
Consolidated Figures in Rs. Crores
| Annual Balance Sheet | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | - |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | - | - | - | 1,046 | 1,113 | 1,310 | 1,875 | 1,963 | 2,146 | 2,252 | 2,743 | - |
| Equity And Liabilities | - | - | - | 1,046 | 1,113 | 1,310 | 1,875 | 1,963 | 2,146 | 2,252 | 2,743 | - |
Shareholding Pattern
Numbers in Percentages
| Quarterly SHP Announcement Date | Mar 2016 12 Apr '16 | Mar 2017 31 Mar '17 | Mar 2018 31 Mar '18 | Mar 2019 05 Apr '19 | Mar 2020 17 Apr '20 | Mar 2021 15 Apr '21 | Mar 2022 13 Apr '22 | Mar 2023 21 Apr '23 | Mar 2024 18 Apr '24 | Mar 2025 18 Apr '25 | Mar 2026 20 Apr '26 | - |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Goverments | - | - | - | - | - | - | - | - | - | - | - | - |
| Promoter And Promoter Group | - | - | - | 53.38% | 53.67% | 53.70% | 53.70% | 53.70% | 53.70% | 54.62% | 54.59% | - |
| Non Institutions | - | - | - | 44.13% | 44.33% | 43.67% | 42.15% | 41.51% | 39.90% | 38.82% | 40.97% | - |
| FII | - | - | - | - | - | - | - | 4.46% | 4.92% | 5.08% | 2.98% | - |
| DII | - | - | - | - | - | - | - | 0.34% | 1.48% | 1.48% | 1.46% | - |
| Total | - | - | - | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | - |
Balaji Amines Ltd
Balaji Amines Ltd
Balaji Amines maintains a significant presence across major geographies, exporting products to more than 40 countries and maintaining long-term relationships with global clients. The company leverages integrated production capabilities and backward integration to drive quality, cost-effectiveness, and timely delivery, positioning itself as a preferred partner for bulk and specialty chemicals.
Balaji Amines Ltd generates revenue through the production and sale of aliphatic amines (including methylamines, ethylamines, and derivatives), specialty chemicals, and performance-based products. Its business model emphasizes cost leadership, operational integration, and strategic expansion into higher-value derivatives and niche chemical segments. The company is engaging in capacity expansion, technology upgrades, and product diversification – notably through new plant setups and greenfield projects to strengthen its specialty chemicals portfolio.
Growth vectors include broadening export markets, developing downstream derivatives for pharmaceutical and agrochemical use, and enhancing operational efficiencies via energy management and digitalization. Strategic focus areas also include ESG compliance, sustainable manufacturing practices, and deeper R&D investments to enter new end-use industries.
CNBC-TV18 India Business Leader Awards 2024 – Shortlisted in Large Corporates category
ISO 9001:2015, ISO 14001:2015 & ISO 45001:2018 certified facilities
Recognized as one of India's Top 500 Companies by Dun & Bradstreet (2023, 2024)
Consistent 'Excellent' supplier ratings from leading global pharmaceutical clients
Received 'Zero Liquid Discharge' certification for environmental compliance at manufacturing sites
Incorporated as Balaji Amines Ltd in Solapur, Maharashtra
Commissioned first methylamines plant
Listed on the Bombay Stock Exchange (BSE)
Listed on National Stock Exchange (NSE)
Commenced commercial production of dimethylformamide (DMF)
Expansion into additional derivatives and specialty chemicals
Established new greenfield plant for specialty chemicals at Solapur MIDC
Launched forward integration project for acetonitrile and N-Methyl-2-Pyrrolidone (NMP) line
Commissioned new energy-efficient manufacturing facility and ramped up R&D investments
Peer Comparison
| S.No. | Company Name | CMP (₹) | Market Cap (₹ Cr) | Div Yld (%) | NP Qtr (₹ Cr) | Qtr Profit Var (%) | Sales Qtr (₹ Cr) | Qtr Sales Var (%) | ROCE (%) | ROE (%) | Book Value (₹) | EPS TTM (₹) | TTMPE Ratio (₹) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Not Found Data | |||||||||||||
Coming Soon
Heatmap View
Premium Feature| Company | CMP (₹) | MCap (₹ Cr) | EPS TTM (₹) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Not Found Data | |||||||||||||
Financial Ratios
Premium Feature| Company Name | P/E (TTM) | EPS (₹) | D/E | NPM | GPM | ROE (%) | ROCE (%) | P/B | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Not Found Data | |||||||||||||
Coming Soon